Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/10/2008EP1999111A2 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
12/10/2008EP1999107A2 Amine derivatives
12/10/2008EP1999104A1 Salt of aliskiren with sulfuric acid
12/10/2008EP1999100A1 Process for preparing memantine hydrochloride substantially free of impurities
12/10/2008EP1999098A2 Compounds that modulate ppar activity, their preparation and use
12/10/2008EP1998808A1 Stable pharmaceutical composition of taxanes
12/10/2008EP1998802A2 Immunogenic composition
12/10/2008EP1998786A2 Reduction of the titratable acidity and the prevention of tooth and other bone degeneration
12/10/2008EP1998785A2 Hedgehog signaling pathway antagonist cancer treatment
12/10/2008EP1998784A1 Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing
12/10/2008EP1998783A2 Ophthalmic compositions comprising povidone-iodine
12/10/2008EP1998782A2 Methods for modulating bladder function
12/10/2008EP1998781A2 Treatment of pain
12/10/2008EP1998780A2 New therapeutic combinations for the treatment or prevention of psychotic disorders
12/10/2008EP1998779A2 Use of (3s)-n-hydroxy-4-({4-ý(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide or (s)-n-hydroxy-4-(4-but-2-ynyloxy-benzenesulfonyl) -2,2-dimethyl-thiomorpholine -3-carboxamide for treating inflammatory skin pathologies
12/10/2008EP1998778A1 Use of (s)-roscovitine for manufacturing a medicine
12/10/2008EP1998777A1 Methods of inhibiting btk and syk protein kinases
12/10/2008EP1998776A2 Pyridine-containing macroheterocylic compounds as kinase inhibitors
12/10/2008EP1998775A2 Bis1,2,3,4-tetrahydroisoquinoline derivatives and their uses as pharmaceuticals
12/10/2008EP1998774A1 Tetrahydroisoquinoline derivatives to enhance memory function
12/10/2008EP1998773A2 New therapeutic combinations for the treatment of depression
12/10/2008EP1998772A2 Use of e-3-[3-[n-(4-methoxybenzenesulfonyl)-n-isopropylamino]phenyl]-3-(3-pyridyl)propenohydroxamic acid for preparing a medicament for preventing and/or treating inflammatory skin pathologies
12/10/2008EP1998771A2 Use of tetrahydropyridines in the treatment of central nervous system disorders
12/10/2008EP1998770A1 Use of cantffln-6-one and its analogues in the treatment of pathologies linked to mycobacteria
12/10/2008EP1998769A2 Treating hiv infection, wherein hiv has a k65r mutation
12/10/2008EP1998768A2 Use of crf1 receptor antagonists for preparing a drug for treating metabolic syndrome and/or obesity and/or dyslipoproteinemia
12/10/2008EP1998767A2 Method for promoting composite tissue regeneration and uses thereof
12/10/2008EP1998766A2 Useful indole compounds
12/10/2008EP1998765A2 Pharmaceutical combinations of hcv-protease and -ires inhibitors
12/10/2008EP1998764A2 Methods for treating cognitive and other disorders
12/10/2008EP1998763A2 Uses of diphenyl/diphenylamine carboxylic acids
12/10/2008EP1998762A2 Solid dosage form containing a taste masked active agent
12/10/2008EP1998761A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
12/10/2008EP1998760A2 Non peptidic molecules for detecting and treating tumors
12/10/2008EP1998759A2 Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related thereto
12/10/2008EP1998758A1 Spray composition for topical use for treating and/or preventing herpes simplex labial infections
12/10/2008EP1998757A1 Milk oligosaccharides for stimulating the immune system
12/10/2008EP1998756A2 Compositions and methods for delivery of amino-functional drugs
12/10/2008EP1998755A2 Chewing gum compositions providing rapid release of nicotine
12/10/2008EP1998754A2 Stable lozenge compositions providing rapid release of nicotine
12/10/2008EP1998753A2 High-deposition compositions and uses thereof
12/10/2008EP1998752A2 Polylactide nanoparticles
12/10/2008EP1998750A2 Mucosal bioadhesive slow release carrier for delivering active principles
12/10/2008EP1998748A2 Improved snuff composition
12/10/2008EP1998739A2 Stable aqueous suspension concentrate for delivery of uv-labile water-insoluble biocides
12/10/2008EP1998684A2 Triggered self-assembly conjugates and nanosystems
12/10/2008EP1998620A2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
12/10/2008EP1998612A2 Substituted biaryl compounds for inflammation and immune-related uses
12/10/2008EP1863479B1 Tetrahydrothiopyrano pyrazole cannabinoid modulators cross reference to related applications
12/10/2008EP1753757B1 Substituted 2,5-diaminomethyl-1h-pyrroles
12/10/2008EP1735312B1 Substituted diaza-spiro-[5.5 -undecane derivatives and their use as neurokinin antagonists
12/10/2008EP1720875B1 8- [3-amino-piperidin-1-yl]-xanthines, the production thereof, and the use of the same as medicaments
12/10/2008EP1718659A4 Vectors having both isoforms of beta-hexosaminidase and uses of the same
12/10/2008EP1706113B1 A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2h-indol-2-one hydrochloride
12/10/2008EP1685130B1 Polymorphs of 1-cyclopropyl-7-([s,s] - 2,8-diazadicyclo [4.3.0] non-8-yl) -6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
12/10/2008EP1681983A4 Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy
12/10/2008EP1677827B1 Combinations for hcv treatment
12/10/2008EP1675855B1 4-amino-quinoline ouinolizidinyl-and quinolizidinylalkyl-derivatives with antimalarial activity
12/10/2008EP1673085A4 C-met modulators and methods of use
12/10/2008EP1664064B1 Oxazaborolidines as bacteria effectors
12/10/2008EP1663185B1 Prevention and treatment of inflammation-induced and/or immune-mediated bone loss
12/10/2008EP1660477B1 Novel farnesyl protein transferase inhibitors as antitumor agents
12/10/2008EP1654271B1 Steroid modified solatrioses
12/10/2008EP1648897B1 N- [3-(3-substituted-pyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-sulfonamides, and compositions, and methods related thereto
12/10/2008EP1613300B1 Photostabilized topical formulations of ketoprofen containing two uv filters
12/10/2008EP1605865B1 Stent with thin film composite laminate
12/10/2008EP1601663B1 Nitrate esters of phenylaminothiophenacetic acid derivatives
12/10/2008EP1562447B1 Antioxidative compositions
12/10/2008EP1558235B1 Methods of treatment during vascular procedures
12/10/2008EP1539765B1 Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists
12/10/2008EP1520044B1 Chromosome 9 genes involved in premature canities
12/10/2008EP1511730B1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/10/2008EP1492501B1 Methods of using lamellar bodies for therapeutic purposes
12/10/2008EP1487410B1 Preparation of sterile stabilized nanodispersions
12/10/2008EP1475382B1 Compounds as semaphorin inhibitors
12/10/2008EP1467735B1 Polymorphs of clopidogrel hydrogensulfate
12/10/2008EP1463545B3 Intraluminal device with a coating containing a therapeutic agent
12/10/2008EP1434589B1 Thioester-terminated water soluble polymers and method of modifying the n-terminus of a polypeptide therewith
12/10/2008EP1404317B1 5-halo-tryptamine derivatives used as ligands of the 5-ht 6? and/or 5-ht 7? serotonin receptors
12/10/2008EP1396487B1 Phenylpyridine carbonyl piperazine derivative
12/10/2008EP1391199B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
12/10/2008EP1386613B1 Topical effervescent composition
12/10/2008EP1346722B1 Method for producing preparation containing bioactive substance
12/10/2008EP1315571B1 Concentric tubular centrifuge
12/10/2008EP1274450B1 Medical uses of agonsist and antagonists of IL-174
12/10/2008EP1252893B1 Medicine containing anemonin as effective component for treating aseptic inflammation
12/10/2008EP1220913B1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof
12/10/2008EP1182939B1 The combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements
12/10/2008EP1163342B1 Chlamydia antigens and corresponding dna fragments and uses thereof
12/10/2008EP1094816B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/10/2008EP1042350B1 Inducible phosphofructokinase and the warburg effect
12/10/2008EP1021464B1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
12/10/2008CN101321869A Modulation of glucagon receptor expression
12/10/2008CN101321775A ODCASE inhibitors for the treatment of malaria
12/10/2008CN101321769A Process for the preparation of purified crystalline CCI-779
12/10/2008CN101321768A 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors
12/10/2008CN101321765A Chromone derivatives useful as antagonists of VR1 receptors
12/10/2008CN101321763A Pyrazolo [1,5-a] pyrimidines as protein kinase inhibitors
12/10/2008CN101321762A Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents
12/10/2008CN101321761A Tricyclic amide derivatives useful for treating obesity
1 ... 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 2972 2973 2974 2975 2976 2977 2978 2979 ... 7860